Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Bree B Aldridge
Affiliation
Tufts University School of Engineering
ORCID
Career Start Year
2006
Papers
47
H Index
22
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36733851
Tools to develop antibiotic combinations that target drug tolerance in <i>Mycobacterium tuberculosis</i>.
Front Cell Infect Microbiol
2023
37549035
Semi-automated colony-forming unit counting for biosafety level 3 laboratories.
STAR Protoc
2023
37278639
Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus.
Antimicrob Agents Chemother
2023
37292927
<i>Mycobacterium tuberculosis</i> grows linearly at the single-cell level with larger variability than model organisms.
bioRxiv
2023
36538813
Advances in the design of combination therapies for the treatment of tuberculosis.
Expert Opin Drug Discov
2023
34599873
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling.
Cell Chem Biol
2022
35365812
Types and functions of heterogeneity in mycobacteria.
Nat Rev Microbiol
2022
35590245
Localization of EccA<sub>3</sub> at the growing pole in Mycobacterium smegmatis.
BMC Microbiol
2022
36480634
Tuberculosis treatment failure associated with evolution of antibiotic resilience.
Science
2022
36549272
How can systems approaches help us understand and treat infectious disease?
Cell Syst
2022
36714853
C25-modified rifamycin derivatives with improved activity against <i>Mycobacterium abscessus</i>.
PNAS Nexus
2022
36084643
Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements.
Cell Rep Med
2022
34226736
The Tuberculosis Drug Accelerator at year 10: what have we learned?
Nat Med
2021
34469743
Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis.
Cell Syst
2021
34628295
Leveraging laboratory and clinical studies to design effective antibiotic combination therapy.
Curr Opin Microbiol
2021
34235676
Efficient Measurement of Drug Interactions with DiaMOND (Diagonal Measurement of N-Way Drug Interactions).
Methods Mol Biol
2021
34228540
Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits.
Antimicrob Agents Chemother
2021
32680963
Morphological profiling of tubercle bacilli identifies drug pathways of action.
Proc Natl Acad Sci U S A
2020
31808676
Setting Our Sights on Infectious Diseases.
ACS Infect Dis
2020
32860732
Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl-1 Inhibitor AZD5991.
CPT Pharmacometrics Syst Pharmacol
2020
30699106
Prediction of ultra-high-order antibiotic combinations based on pairwise interactions.
PLoS Comput Biol
2019
31719182
Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis.
mBio
2019
31249047
Targeting drugs for tuberculosis.
Science
2019
30980069
Definitions and guidelines for research on antibiotic persistence.
Nat Rev Microbiol
2019
31036919
Publisher Correction: Definitions and guidelines for research on antibiotic persistence.
Nat Rev Microbiol
2019
29269274
Engineered cell and tissue models of pulmonary fibrosis.
Adv Drug Deliv Rev
2018
29362232
Stress-Induced Reorganization of the Mycobacterial Membrane Domain.
mBio
2018
29661879
Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action.
Antimicrob Agents Chemother
2018
29619019
Stable Regulation of Cell Cycle Events in Mycobacteria: Insights From Inherently Heterogeneous Bacterial Populations.
Front Microbiol
2018
29026882
Efficient measurement and factorization of high-order drug interactions in <i>Mycobacterium tuberculosis</i>.
Sci Adv
2017
29209302
Influence of Stress and Antibiotic Resistance on Cell-Length Distribution in <i>Mycobacterium tuberculosis</i> Clinical Isolates.
Front Microbiol
2017
29107550
A Parallel Adder Coordinates Mycobacterial Cell-Cycle Progression and Cell-Size Homeostasis in the Context of Asymmetric Growth and Organization.
Curr Biol
2017
29176877
Rv0004 is a new essential member of the mycobacterial DNA replication machinery.
PLoS Genet
2017
27114527
Spatially distinct and metabolically active membrane domain in mycobacteria.
Proc Natl Acad Sci U S A
2016
27357669
Temporal and intrinsic factors of rifampicin tolerance in mycobacteria.
Proc Natl Acad Sci U S A
2016
25016173
Microbial metabolomics: innovation, application, insight.
Curr Opin Microbiol
2014
26104360
The Spectrum of Drug Susceptibility in Mycobacteria.
Microbiol Spectr
2014
25233380
Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection.
PLoS Pathog
2014
23468634
Protein complexes and proteolytic activation of the cell wall hydrolase RipA regulate septal resolution in mycobacteria.
PLoS Pathog
2013
22174129
Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility.
Science
2012
22233444
Polar assembly and scaffolding proteins of the virulence-associated ESX-1 secretory apparatus in mycobacteria.
Mol Microbiol
2012
22108795
Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis.
Mol Syst Biol
2011
19343194
Fuzzy logic analysis of kinase pathway crosstalk in TNF/EGF/insulin-induced signaling.
PLoS Comput Biol
2009
18406323
Quantitative analysis of pathways controlling extrinsic apoptosis in single cells.
Mol Cell
2008
16763565
Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC-depleted cells.
EMBO J
2006
17186704
Direct Lyapunov exponent analysis enables parametric study of transient signalling governing cell behaviour.
Syst Biol (Stevenage)
2006
17060902
Physicochemical modelling of cell signalling pathways.
Nat Cell Biol
2006
1 - 47 of 47
Column Actions
Search
Recommended Authors
Matthew F Wipperman
Regeneron Pharmaceuticals, Inc.
Career Start Year
2012
Number of shared co-authors
1
Bryan D Bryson
Massachusetts Institute of Technology, USA The Ragon Institute of MGH
Career Start Year
2012
Number of shared co-authors
2
Jitender Mehla
University of Oklahoma
Career Start Year
2011
Number of shared co-authors
0
Rohit Vashisht
University of California san francisco
Career Start Year
2009
Number of shared co-authors
0
Bin Hu
Los Alamos National Laboratory
Career Start Year
2008
Number of shared co-authors
0
Richard Copin
Regeneron Pharmaceuticals
Career Start Year
2007
Number of shared co-authors
0
Andrew J Olive
College of Osteopathic Medicine, Michigan State University
Career Start Year
2006
Number of shared co-authors
1
Athanasios Typas
University of California san francisco
Career Start Year
2005
Number of shared co-authors
1
Scott D Pope
Yale School of Medicine, USA Howard Hughes Medical Institute
Career Start Year
2005
Number of shared co-authors
0
Dhiraj Kumar
Johns Hopkins University School of Medicine
Career Start Year
2004
Number of shared co-authors
1
Oren S Rosenberg
University of California san francisco
Career Start Year
2003
Number of shared co-authors
3
David Marciano
Stanford Cardiovascular Institute (L.W., Stanford University School of Medicine
Career Start Year
2003
Number of shared co-authors
0
Pooja Agarwal
SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, University of Cape Town
Career Start Year
2003
Number of shared co-authors
0
Michael A Fischbach
Stanford University
Career Start Year
2003
Number of shared co-authors
2
George P Tegos
Drexel University College of Medicine
Career Start Year
2002
Number of shared co-authors
0
Hugh D Mitchell
Pacific Northwest National Laboratory (PNNL)
Career Start Year
2002
Number of shared co-authors
0
Sarah A Stanley
University of California berkeley
Career Start Year
2001
Number of shared co-authors
1
Jason F Kreisberg
University of California San Diego
Career Start Year
2000
Number of shared co-authors
2
Zhonghe Sun
Jiangsu University
Career Start Year
1997
Number of shared co-authors
0
Ariel B Lindner
Universite Paris Cite, Inserm
Career Start Year
1997
Number of shared co-authors
0
Matthias Wittwer
F. Hoffmann-La Roche Ltd.
Career Start Year
1997
Number of shared co-authors
1
Michael S Glickman
Memorial Sloan Kettering Cancer Center
Career Start Year
1997
Number of shared co-authors
2
Paul J Hergenrother
University of Illinois at Urbana-Champaign
Career Start Year
1995
Number of shared co-authors
2
Rodrigo Andres Floto
University of Cambridge
Career Start Year
1995
Number of shared co-authors
0
Paul de Figueiredo
Texas A&M University, College Station
Career Start Year
1995
Number of shared co-authors
1
Simon Tiberi
University of Bologna
Career Start Year
1991
Number of shared co-authors
0
Zolt??n N Oltvai
University of Rochester
Career Start Year
1991
Number of shared co-authors
0
Maria Laura Gennaro
Public Health Research Institute, Rutgers New Jersey Medical School
Career Start Year
1980
Number of shared co-authors
1
Douglas B Kell
Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark
Career Start Year
1978
Number of shared co-authors
2
David C Hooper
Massachusetts General Hospital
Career Start Year
1962
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Peter K Sorger
Co-authored papers
6
Douglas A Lauffenburger
Massachusetts Institute of Technology
Co-authored papers
5
Jennifer M Hayashi
Gladstone Institutes
Co-authored papers
2
Artem Sokolov
Harvard Medical School
Co-authored papers
2
Kim Lewis
Co-authored papers
2
David R Sherman
University of Washington
Co-authored papers
1
Wesley C Van Voorhis
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Co-authored papers
1
John Leszyk
Co-authored papers
1
Scott A Shaffer
Co-authored papers
1
Kevin A Janes
University of Virginia
Co-authored papers
1
David L Kaplan
Co-authored papers
1
Case W McNamara
a division of The Scripps Research Institute La Jolla
Co-authored papers
1
Naeha Subramanian
Institute for Systems Biology
Co-authored papers
1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers
1
Claire L Carter
Co-authored papers
1
Shirit Einav
Stanford University School of Medicine
Co-authored papers
1
Jeremy L Muhlich
Co-authored papers
1
Jeremy M Rock
The Rockefeller University
Co-authored papers
1
Jason H Yang
Rutgers New Jersey Medical School
Co-authored papers
1
Mehmet Toner
Co-authored papers
1
Christina E Baer
Co-authored papers
1
Ronald N Germain
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
1
Benjamin F Cravatt
Scripps Research Institute
Co-authored papers
1
Anna Kuchina
University of Washington
Co-authored papers
1
Jason A Papin
University of Virginia
Co-authored papers
1
Julio Saez-Rodriguez
Institute of Computational Biomedicine, Heidelberg University
Co-authored papers
1
Sriram Chandrasekaran
University of Michigan ann arbor
Co-authored papers
1
Frederick S Buckner
University of Washington
Co-authored papers
1
John P Overington
Institute of Cardiovascular Science, University College London
Co-authored papers
1
Tom Alber
University of California berkeley
Co-authored papers
1
1 - 30